NOVLASE
Novel light sources for biomedical-imaging applications
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0NOVLASE project word cloud
Explore the words cloud of the NOVLASE project. It provides you a very rough idea of what is the project "NOVLASE" about.
Project "NOVLASE" data sheet
The following table provides information about the project.
| Coordinator |
BRIGHTERWAVE OY
Organization address contact info |
| Coordinator Country | Finland [FI] |
| Project website | http://www.brighterwave.com |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies) |
| Code Call | H2020-SMEINST-1-2015 |
| Funding Scheme | SME-1 |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-12-01 to 2016-05-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | BRIGHTERWAVE OY | FI (TAMPERE) | coordinator | 50˙000.00 |
Map
Project objective
Narrow band light sources can provide doctors such information on a patient which is not (or is barely) visible using conventional white light sources. Narrow band light sources can improve both the early detection of cancer as well as the early detection of diabetes. Traditional white light sources (like Xenon lamp) are heavy, expensive and the lamp needs to be regularly replaced. Laser light sources are gradually replacing white light sources due to their advantages but current lasers are complex, expensive and only few wavelengths/colours are available.
Our novel proprietary laser technology solves these issues thanks to new innovative nanostructures which we have developed and integrated to our laser components. The technology allows cost-efficient fabrication of any visible wavelength/colour and products are served to customers in an ultra-compact package with standard easy-to-use interface.
The initial market segment for the laser module developed and sampled to customers in Phase 1 is Narrow Band Imaging application for endoscopic diagnostics. Global endoscopy instrument market is expected to grow from $23.3 billion in 2010 to $33.7 billion in 2016. In Phase 2, we expand our product portfolio by introducing more wavelengths/colours to retina imaging application. We also kick off mass-production with our existing European production partners to satisfy the demand for our products. Most key customers (and competitors) locate in USA, Japan and China.
Our technology platform allows us to enter several applications in emerging biomedical-imaging, industrial and consumer electronics markets. NOVLASE boosts our product development and helps us introduce new products to these new markets faster. We expect to need 1.0 – 1.5 m€ in Phase 2 and raise a venture funding in the end of the project to secure the projected strong growth.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NOVLASE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "NOVLASE" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)
S3D (2015)
Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.
Read More